The Serum Institute of India has asked for permission to use its Covishield vaccine as a booster, citing adequate stock and emergence of new variants of the virus, the PTI reported citing unnamed sources.
The company, which makes and sells the Oxford- AstraZeneca Plc shot in India, filed the application with the Drug Controller General of India, the report said, pointing out that there was no shortage of vaccine in India. It also cited the example of the U.K. that has approved booster doses, the report said.
Serum Institute recently got permission to resume exports for Covax, the global distribution programme.